AnaptysBio, Inc. (NASDAQ:ANAB – Get Free Report) Director J. Anthony Ware sold 3,900 shares of the firm’s stock in a transaction on Tuesday, December 23rd. The stock was sold at an average price of $49.58, for a total value of $193,362.00. Following the transaction, the director owned 9,630 shares of the company’s stock, valued at […]

AnaptysBio, Inc. (NASDAQ:ANAB – Get Free Report) CFO Dennis Mulroy sold 10,000 shares of the business’s stock in a transaction that occurred on Monday, December 22nd. The shares were sold at an average price of $50.00, for a total value of $500,000.00. Following the sale, the chief financial officer owned 9,401 shares of the company’s […]

AnaptysBio, Inc. (NASDAQ:ANAB – Get Free Report) insider Eric Loumeau sold 10,000 shares of the company’s stock in a transaction that occurred on Monday, December 22nd. The stock was sold at an average price of $51.00, for a total value of $510,000.00. Following the sale, the insider owned 8,947 shares in the company, valued at […]

AnaptysBio, Inc. (NASDAQ:ANAB – Get Free Report) insider Eric Loumeau sold 10,000 shares of the business’s stock in a transaction on Wednesday, December 17th. The stock was sold at an average price of $46.00, for a total transaction of $460,000.00. Following the transaction, the insider directly owned 9,088 shares of the company’s stock, valued at […]

AnaptysBio, Inc. (NASDAQ:ANAB – Get Free Report) CFO Dennis Mulroy sold 15,725 shares of the firm’s stock in a transaction dated Tuesday, December 16th. The stock was sold at an average price of $44.85, for a total value of $705,266.25. Following the transaction, the chief financial officer owned 9,401 shares of the company’s stock, valued […]